Search

everythinglearnresearchcommunity

for

Search:↓

RC48 shows promise for treating certain advanced cancers, but more research is needed.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Dupilumab may cause hair loss in some patients with severe atopic dermatitis.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

Dupilumab can cause unexpected scalp issues, so early symptom recognition is important to avoid hair loss.

BMS-470539 reduces skin fibrosis and inflammation.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

JAK inhibitors may help improve symptoms in adults with APECED.

Dupilumab users have a higher risk of developing alopecia areata.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Ustekinumab effectively treated psoriasis and ulcerative colitis in a teen after infliximab caused complications.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Trametinib can cause skin issues, but they can often be managed without stopping the drug.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Upadacitinib effectively treats psoriasis and lichen planus together.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Repeated biopsies are crucial for managing lupus panniculitis when initial treatments fail.

PLD is an effective and safer alternative for treating breast cancer.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.